PRMT5 and esophageal squamous cell carcinoma: It showed that the PRMT5 expression in clinical ESCC tissues and ESCC cell lines was abnormal, and we next explored the effects of PRMT5 in ESCC cells by transfecting siRNA-PRMT5 in ECA109 and KYSE150 cells.